Sandra joined CD&R in 2019 and works across our healthcare and consumer investments in North America and Europe. Prior to CD&R, she was group worldwide chairman of Johnson & Johnson, where she led the consumer and medical devices businesses and was responsible for the corporation’s global supply chain, as well as its technology strategy and operating infrastructure. Previously, Sandra served as CEO of Bayer CropScience AG, CEO of Bayer Medical Care, and president of Bayer HealthCare AG’s Diabetes Care Division. She started her career at McKinsey and has held executive positions at Medco Health Solutions (fka Merck-Medco), Nabisco, and Whirlpool. Sandra is the lead independent director for the Microsoft board of directors. She is also chairman of Volastra, an early-stage life science company. In addition, she is chairman of the board of the American Academy in Berlin, and executive committee member and trustee of the Institute for Advanced Study, the world-renowned center for science, math, and humanities research in Princeton, NJ. Sandra is an Advisor to Hakluyt & Company, a British based, global advisory firm as well as Temasek, a Singaporean based investment firm. Sandra has an M.P.A. in Applied Economics from Princeton University and a B.A. in Government from Cornell University.

CD&R Investments

• Aster Insights / Zephyr

• Covetrus

• Cynosure